Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study

• Jarushka Naidoo,
• Ryan Sullivan,
• Meghan J Mooradian,
• Leyre Zubiri,
• Vartan Pahalyants,
• Nicholas Theodosakis,
• Kerry L Reynolds,
• Yevgeniy R Semenov,
• Meghan E Sise,
• James Iheke,
• Pearl Ugwu-Dike,
• Jayhyun Seo,
• Kimberly Tang,
• Bruce C Tiu

Affiliations

Jarushka Naidoo

Medical Oncology, Department of Medicine, Beaumont Hospital Dublin and RCSI University of Health Sciences, Dublin, Ireland

Ryan Sullivan

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

Meghan J Mooradian

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

Leyre Zubiri

Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Vartan Pahalyants

Harvard Medical School, Boston, Massachusetts, USA

Nicholas Theodosakis

2Massachusetts General Hospital, Boston, MA, USA

Kerry L Reynolds

Division of Oncology, Massachusetts General Hospital, Boston, MA, USA

Yevgeniy R Semenov

Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Meghan E Sise

Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA

James Iheke

3University of Alabama at Birmingham SoM, Birmingham, AL, United States

Pearl Ugwu-Dike

2Massachusetts General Hospital, Boston, MA, United States

Jayhyun Seo

2Massachusetts General Hospital, Boston, MA, United States

Kimberly Tang

2Massachusetts General Hospital, Boston, MA, United States

Bruce C Tiu

Harvard Medical School, Boston, Massachusetts, USA